Table 2.

Delphi 3 Responses

PROBLEM-TREATMENT	MEAN	MEDIAN	CONFIDENCE INTERVAL AROUND MEDIAN (α = 0.05)
			Lower Limit	Upper Limit
Uveitis (JRA, sarcoid, or idiopathic) unresponsive to MTX treated with infliximab	2.86	2	1	3
Systemic onset JRA treated with anakinra	3.68	3	3	4
Pediatric SLE treated with MMF	4.15	4	3	5
JDM unresponsive to prednisone and DMARDS treated with etanercept	4.59	4	4	6
Systemic onset JRA treated with thalidomide	4.28	5	3	5
Thrombocytopenia unresponsive to standard therapy in SLE treated with rituximab	4.57	5	4	5
Localized Scleroderma treated with steroids and MTX	4.88	5	4	6
Pauci-articular JRA with uveitis, with early treatment	6.97	8	8	8

JRA: Juvenile Rheumatoid Arthritis

MTX: Methotrexate

SLE: Systemic Lupus Erythematosus

MMF: Mycophenolate mofetil

JDM: Juvenile Dermatomyositis

DMARDS: Disease-Modifying Anti-Rheumatic Drugs